LATEST
EQT agreed to acquire CleanawaynewNavigator Gas / Navigator HoldingsAlcoa / AliGroupInternational Seaways agreed to acquire BrutonBoston Crest PVT / LQR HouseBrady acquired Productivity Solutions and Services businessJMSB / EFSIVista Equity Partners / PKI Business UnitBluegem Capital Partners / Rispo GroupApax Partners agreed to acquire OdidoGTCR agreed to acquire CCC Intelligent SolutionsEQT agreed to acquire Stockbridge
Open App
ClosedPublished 9 Oct 2025

XenoTherapeutics /
ESSA

XenoTherapeutics completes acquisition of ESSA Pharma

Buy side: XenoTherapeutics
Buy sideXenoTherapeutics
Target: ESSA
TargetESSA
ESSA Pharma Inc. · 9 Oct 2025Source
See the source
Buy side: XenoTherapeutics
Buy sideXenoTherapeutics
Target: ESSA
TargetESSA
01 / BuyerXenoTherapeutics
02 / TargetESSA
Source for the buyer and target: ESSA Pharma Inc.

For the buyer and target.

“ESSA Pharma Inc. (NASDAQ: EPIX) (“ESSA” or the “Company”) today announced the completion of XenoTherapeutics’ (“Xeno”) previously announced acquisition of ESSA (the “Acquisition”).”

Published 9 Oct 2025

Open the source
01

What happened

XenoTherapeutics completed its acquisition of ESSA, with Xeno Acquisition Corp. acquiring all of ESSA’s outstanding common shares. [01]

Shareholders received approximately US$0.1242 per Common Share, plus one contingent value right. The potential CVR payment represents up to US$6.7 million in the aggregate. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · ESSA Pharma Inc.

XenoTherapeutics completes acquisition of ESSA Pharma

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by ESSA Pharma Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.